These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

66 related items for PubMed ID: 17505926

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.
    Taha TE, Kumwenda J, Cole SR, Hoover DR, Kafulafula G, Fowler MG, Thigpen MC, Li Q, Kumwenda NI, Mofenson L.
    J Infect Dis; 2009 Nov 15; 200(10):1490-7. PubMed ID: 19832114
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. User fees and access to ARV treatment for persons living with HIV/AIDS: implementation and challenges in Burkina Faso, a limited-resource country.
    Kouanda S, Bocoum FY, Doulougou B, Bila B, Yameogo M, Sanou MJ, Sawadogo M, Sondo B, Msellati P, Desclaux A.
    AIDS Care; 2010 Sep 15; 22(9):1146-52. PubMed ID: 20824567
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
    Pozio E.
    Parassitologia; 2004 Jun 15; 46(1-2):89-93. PubMed ID: 15305694
    [Abstract] [Full Text] [Related]

  • 10. Scaling up access to antiretroviral treatment for HIV infection: the impact of decentralization of healthcare delivery in Cameroon.
    Boyer S, Eboko F, Camara M, Abé C, Nguini ME, Koulla-Shiro S, Moatti JP.
    AIDS; 2010 Jan 15; 24 Suppl 1():S5-15. PubMed ID: 20023440
    [Abstract] [Full Text] [Related]

  • 11. AIDS mortality before and after the introduction of highly active antiretroviral therapy: does it vary with socioeconomic group in a country with a National Health System?
    Borrell C, Rodríguez-Sanz M, Pasarín MI, Brugal MT, García-de-Olalla P, Marí-Dell'Olmo M, Caylà J.
    Eur J Public Health; 2006 Dec 15; 16(6):601-8. PubMed ID: 16698886
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Usefulness of an observational database to assess antiretroviral treatment trends in India.
    Cecelia AJ, Christybai P, Anand S, Jayakumar K, Gurunathan T, Vidya P, Solomon S, Kumarasamy N.
    Natl Med J India; 2006 Dec 15; 19(1):14-7. PubMed ID: 16570679
    [Abstract] [Full Text] [Related]

  • 15. Effectiveness of antiretroviral treatment in a South African program: a cohort study.
    Fairall LR, Bachmann MO, Louwagie GM, van Vuuren C, Chikobvu P, Steyn D, Staniland GH, Timmerman V, Msimanga M, Seebregts CJ, Boulle A, Nhiwatiwa R, Bateman ED, Zwarenstein MF, Chapman RD.
    Arch Intern Med; 2008 Jan 14; 168(1):86-93. PubMed ID: 18195200
    [Abstract] [Full Text] [Related]

  • 16. Pediatric HIV costs across three treatment eras from 1986 to 2007.
    Wilson LS, Basu R, Christenson M, Hensic L, Paoli C, Wara D, Moskowitz JT.
    Pediatrics; 2010 Sep 14; 126(3):e541-9. PubMed ID: 20696721
    [Abstract] [Full Text] [Related]

  • 17. Quality of life and needs assessment on people living with HIV and AIDS in Malawi.
    Fan AP, Kuo HC, Kao DY, Morisky DE, Chen YM.
    AIDS Care; 2011 Mar 14; 23(3):287-302. PubMed ID: 21347892
    [Abstract] [Full Text] [Related]

  • 18. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.
    Palombi L, Marazzi MC, Voetberg A, Magid NA.
    AIDS; 2007 Jul 14; 21 Suppl 4():S65-71. PubMed ID: 17620755
    [Abstract] [Full Text] [Related]

  • 19. When to initiate highly active antiretroviral therapy in sub-Saharan Africa? A South African cost-effectiveness study.
    Badri M, Cleary S, Maartens G, Pitt J, Bekker LG, Orrell C, Wood R.
    Antivir Ther; 2006 Jul 14; 11(1):63-72. PubMed ID: 16518961
    [Abstract] [Full Text] [Related]

  • 20. Who is accessing antiretroviral therapy during national scale-up in Malawi?
    Makombe S, Libamba E, Mhango E, de Ascurra Teck O, Aberle-Grasse J, Hochgesang M, Schouten EJ, Harries AD.
    Trans R Soc Trop Med Hyg; 2006 Oct 14; 100(10):975-9. PubMed ID: 16443244
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.